2009 Fiscal Year Final Research Report
The effected of cancer gene therapy for Del 1 and Fas L
| Project/Area Number |
20791551
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Surgical dentistry
|
|---|
| Research Institution | Nihon University |
|---|
Principal Investigator |
KITANO Hisataka Nihon University, 医学部, 専修医 (50424726)
|
|---|
| Project Period (FY) |
2008 – 2009
|
| Keywords | 癌 / 遺伝子 / 蛋白質 / バイオテクノロジー |
|---|
| Research Abstract |
FasL and FasL/E3D1 was made and transfected for a cancer cell. In this examination, the transfected cells were concentrated to FasL protein for ECM by Del1. Andmore, the protein was effected to apoptosis and, second gene transfer. It was shown that the organization could concentrate it without a composed domain of Del1 losing the function with various kinds of bioactive substances.
|
